PTCL, PharmEvo for Wifi zones in hospitals
Islamabad (October 4, 2012) – To spread awareness about health issues and facilitate doctors, Pakistan Telecommunication Company Limited (PTCL) and PharmEvo, a giant of local pharmaceutical sector, have joined hands.
In a graceful ceremony on Friday evening at a local hotel, PTCL and Pharmevo signed an agreement under which PTCL would provide PharmEvo with technical support to establish ‘Wifi Zones’ in hospitals. This initiative of PharmEvo is a part of its innovative campaign entitled ‘NICE Initiative in Spreading E-Health (NISE Campaign).
PharmEvo Chief Executive Officer Syed Jamshed Ahmed and PTCL Executive Vice President Zaman Gulzar signed the agreement.
Speaking on the occasion, Ahmed said that PharmEvo had collected latest research-based medicines and health related instruments from across the world, which they wanted to share with doctors. He said that they also intended to support health experts and doctors with provision of latest information so as to save precious lives and enhance the expertise of health professionals. In this regard, he added, they were requiring technical support, which now they got from PTCL.
He further said the information technology revolution is being described as the most important development in the history of humankind, since the industrial revolution characterised as ‘The Third Wave’ by Alvin Toffler–Associate Editor of Fortune Magazine.
Keeping in view the continuing advances in information and communication technology, the applications of computers in medicine had increased rapidly, and have acquired the potential to revolutionise healthcare, he said.
Quoting a survey by the Royal College of Surgeons of Edinburgh, he said that health surfers, including doctors, are the biggest measurable group of web users.
He said PharmEvo understood its responsibility to protect the environment for their present and future generations.
He said, “Under the umbrella of this campaign, PharmEvo has planned to develop ‘Wifi Zones’ across Pakistan in public and private hospitals to provide an uninterrupted internet facility to healthcare professionals.
Through this, they can access telemedicine as well as advances in health screening and assessment, computer-based training and education in different fields of medicine, and information available on database search sites.
The project will also enable healthcare professionals to communicate and exchange invaluable expertise with each other. This, in turn, will help them in treating difficult and complicated cases by seeking expert opinions online. This could well lead to valuable innovations and discoveries and saving precious human lives.”
Zaman Gulzar, in his speech, hailed the role of PharmEvo and said that with the technical support of PTCL, the admirable health awareness programme of PharmEvo would bring revolutionary developments in health sector for masses in Pakistan. He said they were delighted and felt very happy to provide EVO and EVO Nitro services to PharmEvo and their associated medical community. “We assure them of state of the art service, 24×7 support and PTCL commitment. We look forward to extend this relationship in other areas as well.”
Besides, PTCL and PharmEvo high-ups, a number of professionals, belonging to health and communication sector were present on the occasion.
About PharmEvo Private Limited
PharmEvo belongs to a corporate group who is in diversified businesses since 1971, started with distribution of pharmaceuticals & consumer products and later ventured into manufacturing of baby care / dental care products, pharmaceuticals, textile, food & others. Currently group employees are more than 3,000 people.
PharmEvo started its operation in 2000 as manufacturing & marketing company and since then it is a success story, inspiration & model for others to follow locally and globally.
Today PharmEvo is a team of approx. 600 people, offering wide range of formulations with an unpredicted growth of 40% over the years. Our focus is to offer solutions in major therapeutic categories through quality and ethics.